Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 406 AL 420

The role of exosome-shuttled miRNAs in heavy metal-induced peripheral tissues and neuroinflammation in Alzheimer's disease

Dong Q, Fu H, Jiang H.

Biomed Pharmacother. 2024 Jul;176:116880. doi: 10.1016/j.biopha.2024.116880. Epub 2024 Jun 7.

The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease

Balusu S, De Strooper B.

Acta Neuropathol. 2024 Jun 9;147(1):96. doi: 10.1007/s00401-024-02747-5.

Differences in Cognitive Trajectories of Dementia: Comparison of Alzheimer's Disease Dementia and Dementia with Lewy Bodies in a Korean Patient Cohort

Cho BH, Kim H, Choi SM, Cho SH, Kim BC.

Dement Geriatr Cogn Disord. 2024;53(5):255-264. doi: 10.1159/000539743. Epub 2024 Jun 8.

Multi-target drugs for Alzheimer's disease

Turgutalp B, Kizil C.

Trends Pharmacol Sci. 2024 Jul;45(7):628-638. doi: 10.1016/j.tips.2024.05.005. Epub 2024 Jun 9.

Hippocampal transcriptome-wide association study and pathway analysis of mitochondrial solute carriers in Alzheimer's disease

Tian J, Jia K, Wang T, Guo L, Xuan Z, Michaelis EK, Swerdlow RH; Alzheimer’s Disease Neuroimaging Initiative; Du H.

Transl Psychiatry. 2024 Jun 10;14(1):250. doi: 10.1038/s41398-024-02958-0.

Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)

Zeng L, Perin J, Gross AL, Shade D, Lanctôt KL, Lerner AJ, Mintzer JE, Brawman-Mintzer O, Padala PR, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Herrmann N, Rosenberg PB.

Int J Geriatr Psychiatry. 2024 Jun;39(6):e6108. doi: 10.1002/gps.6108.

Signaling pathways in the treatment of Alzheimer's disease with acupuncture: a narrative review

Ke C, Shan S, Tan Y, Cao Y, Xie Z, Shi S, Pan J, Zhang W.

Acupunct Med. 2024 Aug;42(4):216-230. doi: 10.1177/09645284241256669. Epub 2024 Jun 10.

Beyond amyloid and tau: rethinking Alzheimer's disease through less explored avenues

Gyimesi M, Okolicsanyi RK, Haupt LM.

Open Biol. 2024 Jun;14(6):240035. doi: 10.1098/rsob.240035. Epub 2024 Jun 12.

Predicting how many people might receive treatment with new therapies for Alzheimer's disease

Underwood BR.

J Neurol Neurosurg Psychiatry. 2024 Aug 16;95(9):793. doi: 10.1136/jnnp-2024-333941.

An Epigenetic Manifestation of Alzheimer's Disease: DNA Methylation

Feng B, Zheng J, Cai Y, Han Y, Han Y, Wu J, Feng J, Zheng K.

Actas Esp Psiquiatr. 2024 Jun;52(3):365-374. doi: 10.62641/aep.v52i3.1595.

Cerebrovascular Endothelial Dysfunction: Role of BACE1

Katusic ZS, d'Uscio LV, He T.

Arterioscler Thromb Vasc Biol. 2024 Aug;44(8):1737-1747. doi: 10.1161/ATVBAHA.124.320798. Epub 2024 Jun 13.

Influence of Tau on Neurotoxicity and Cerebral Vasculature Impairment Associated with Alzheimer's Disease

Rather MA, Khan A, Jahan S, Siddiqui AJ, Wang L.

Neuroscience. 2024 Aug 6;552:1-13. doi: 10.1016/j.neuroscience.2024.05.042. Epub 2024 Jun 12.

MicroRNAs and synapse turnover in Alzheimer's disease

Dalal S, Ramirez-Gomez J, Sharma B, Devara D, Kumar S.

Ageing Res Rev. 2024 Aug;99:102377. doi: 10.1016/j.arr.2024.102377. Epub 2024 Jun 12.

Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer's Disease: Findings from Clinical Trials

Chen X, Walton K, Brodaty H, Chalton K.

J Alzheimers Dis. 2024;101(s1):S479-S501. doi: 10.3233/JAD-231222.

Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems

Loeffler DA.

J Alzheimers Dis. 2024;100(2):379-411. doi: 10.3233/JAD-240212.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias